Vimarsana
Biggest News Aggregation in the World

Page 10 - Access Bio News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Access Bio. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Access Bio Today - Breaking & Trending Today

Intrivo Diagnostics Secures National Distribution Agreement with McKesson Medical-Surgical for Access Bio CareStart™ COVID-19 Tests - Vimarsana News

Intrivo Diagnostics Secures National Distribution Agreement with McKesson Medical-Surgical for Access Bio CareStart™ COVID-19 Tests

Intrivo Diagnostics Secures National Distribution Agreement with McKesson Medical-Surgical for Access Bio CareStart™ COVID-19 Tests LOS ANGELES, Dec. 17, 2020 — NDC, Inc. as key national partners within the Healthcare Supply Chain to help bring the CareStart™ line of COVID-19 testing products to the US market. “Our agreement with McKesson Medical-Surgical is a monumental step in our efforts to reopen America through the use of rapid testing on a mass scale. By enhancing our supply chain to ensure greater access to Access Bio’s testing products, we can play a large role in curbing...

Ginkgo Bioworks Funds Expansion of Rapid Antigen Test Manufacturing with Access Bio in New Jersey - Vimarsana News

Ginkgo Bioworks Funds Expansion of Rapid Antigen Test Manufacturing with Access Bio in New Jersey

Ginkgo Bioworks Funds Expansion of Rapid Antigen Test Manufacturing with Access Bio in New Jersey November 22, 2020 Securing access to 10 million rapid antigen tests, which are EUA authorized and available today through Concentric by Ginkgo BOSTON, Nov. 20, 2020 /PRNewswire/ — Today, Ginkgo Bioworks announced it has secured access to at least 10 million rapid antigen test kits from Access Bio, a global in vitro diagnostics company. The tests will be available through Concentric by Ginkgo, the company’s end-to-end service for COVID-19 testing, for organizations seeking to use testing as...

Intrivo Diagnostics Secures National Distribution Agreement with McKesson Medical-Surgical for Access Bio Care - Vimarsana News

Intrivo Diagnostics Secures National Distribution Agreement with McKesson Medical-Surgical for Access Bio Care

NDC, Inc. as key national partners within the Healthcare Supply Chain to help bring the CareStart™ line of COVID-19 testing products to the US market. “Our agreement with McKesson Medical-Surgical is a monumental step in our efforts to reopen America through the use of rapid testing on a mass scale. By enhancing our supply chain to ensure greater access to Access Bio’s testing products, we can play a large role in curbing the spread of this virus,” said Reeve Benaron, Founder, Chairman and CEO, Intrivo Diagnostics. “We are delighted to welcome McKesson to our family of authorized di...

Letter: A better COVID testing strategy - Vimarsana News

Letter: A better COVID testing strategy

Letter: A better COVID testing strategy Published: 12/16/2020 12:01:45 AM It is amazing that the White House has not had a COVID outbreak from March until October. This is despite the fact that the White House and its events are mostly non-mask-wearing and ignore public health practices. This has been done mostly through the use of the Binax and the Access Bio COVID Antigen tests. Even though these tests may have less accuracy, they have demonstrated they are effective. We have largely medicalized COVID testing. Get a prescription, wait in line, and wait up to three days for a result. At a pr...